Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) EBT: 2015-2024

Historic EBT for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to -$145.2 million.

  • Anaptysbio's EBT rose 146.00% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year increase of 48.96%. This contributed to the annual value of -$145.2 million for FY2024, which is 11.24% up from last year.
  • Per Anaptysbio's latest filing, its EBT stood at -$145.2 million for FY2024, which was up 11.24% from -$163.6 million recorded in FY2023.
  • Anaptysbio's EBT's 5-year high stood at -$19.9 million during FY2020, with a 5-year trough of -$163.6 million in FY2023.
  • For the 3-year period, Anaptysbio's EBT averaged around -$145.9 million, with its median value being -$145.2 million (2024).
  • In the last 5 years, Anaptysbio's EBT skyrocketed by 79.56% in 2020 and then crashed by 189.98% in 2021.
  • Over the past 5 years, Anaptysbio's EBT (Yearly) stood at -$19.9 million in 2020, then tumbled by 189.98% to -$57.8 million in 2021, then crashed by 122.68% to -$128.7 million in 2022, then dropped by 27.14% to -$163.6 million in 2023, then climbed by 11.24% to -$145.2 million in 2024.